Answers are grounded in this paper and cite their sources.
Observational report assesses safety and risks of whole blood transfusion in Norway, suggesting improved hemovigilance is essential.
These findings indicate that WB transfusion in Norway is safe. However, there are inherent risks for blood transfusion in general and also risks more specific to WB transfusion. These include the presence of red blood cell alloantibodies anti-A and anti-B combined with approximately 250 mL plasma from a single donor. Accurate and timely hemovigilance work is important to safeguard patient outcomes and provide a foundation for targeted risk mitigation strategies for WB transfusion.
No takes yet. Share an insight, caveat, or question.
Erikstein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: